Lisa Blackwell
Overview
Explore the profile of Lisa Blackwell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
3706
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hacke W, Lyden P, Emberson J, Baigent C, Blackwell L, Albers G, et al.
Int J Stroke
. 2017 Nov;
13(2):175-189.
PMID: 29171359
Background The recommended maximum age and time window for intravenous alteplase treatment of acute ischemic stroke differs between the Europe Union and United States. Aims We compared the effects of...
2.
OLynn C, Cooper A, Blackwell L
JBI Database System Rev Implement Rep
. 2017 Nov;
15(11):2707-2722.
PMID: 29135751
Background: Clinical practice frequently involves the practitioner touching patients' bodies in areas that are highly personal. If inappropriately performed, such intimate touch may result in much anxiety, confusion and misinterpretation....
3.
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al.
Lancet
. 2016 Sep;
388(10059):2532-2561.
PMID: 27616593
This Review is intended to help clinicians, patients, and the public make informed decisions about statin therapy for the prevention of heart attacks and strokes. It explains how the evidence...
4.
OLynn C, Cooper A, Blackwell L
JBI Database System Rev Implement Rep
. 2016 Aug;
14(6):96-102.
PMID: 27532654
What are the perceptions, experiences and preferences of patients receiving the clinician's touch during intimate care and procedures?
5.
Lees K, Emberson J, Blackwell L, Bluhmki E, Davis S, Donnan G, et al.
Stroke
. 2016 Aug;
47(9):2373-9.
PMID: 27507856
Background: Thrombolytic therapy with intravenous alteplase within 4.5 hours of ischemic stroke onset increases the overall likelihood of an excellent outcome (no, or nondisabling, symptoms). Any improvement in functional outcome...
6.
Herrington W, Emberson J, Mihaylova B, Blackwell L, Reith C, Solbu M, et al.
Lancet Diabetes Endocrinol
. 2016 Aug;
4(10):829-39.
PMID: 27477773
Background: Statin therapy is effective for the prevention of coronary heart disease and stroke in patients with mild-to-moderate chronic kidney disease, but its effects in individuals with more advanced disease,...
7.
Whiteley W, Emberson J, Lees K, Blackwell L, Albers G, Bluhmki E, et al.
Lancet Neurol
. 2016 Jun;
15(9):925-933.
PMID: 27289487
Background: Randomised trials have shown that alteplase improves the odds of a good outcome when delivered within 4·5 h of acute ischaemic stroke. However, alteplase also increases the risk of...
8.
Lindley R, Wardlaw J, Whiteley W, Cohen G, Blackwell L, Murray G, et al.
Stroke
. 2015 Jan;
46(3):746-56.
PMID: 25613308
Background And Purpose: Our aim was to identify whether particular subgroups of patients had an unacceptably high risk of symptomatic intracranial hemorrhage or low chance of benefit when treated with...
9.
Fulcher J, OConnell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, et al.
Lancet
. 2015 Jan;
385(9976):1397-405.
PMID: 25579834
Background: Whether statin therapy is as effective in women as in men is debated, especially for primary prevention. We undertook a meta-analysis of statin trials in the Cholesterol Treatment Trialists'...
10.
Emberson J, Lees K, Lyden P, Blackwell L, Albers G, Bluhmki E, et al.
Lancet
. 2014 Aug;
384(9958):1929-35.
PMID: 25106063
Background: Alteplase is effective for treatment of acute ischaemic stroke but debate continues about its use after longer times since stroke onset, in older patients, and among patients who have...